In­ter­moun­tain stud­ies ge­nomics

Health Data Management - - NEWSLINE - —Greg Slabodkin

In­ter­moun­tain Health­care is launch­ing a long-term prospec­tive study to help physi­cians and re­searchers un­lock the po­ten­tial value of ge­nomic data in or­der to ad­vance pre­ci­sion medicine. The sys­tem-wide study, called PRE­CISE, will en­able the se­rial col­lec­tion of tis­sue and blood spec­i­mens from healthy in­di­vid­u­als, as well as pa­tients with dis­eases treated at In­ter­moun­tain Health­care, and then at­tempt to link the ge­nomic data to clin­i­cal out­comes in the fu­ture. “The gen­eral col­lec­tion pro­to­col al­lows us, in a very broad fash­ion, to col­lect left­over spec­i­mens from pa­tients that would nor­mally be dis­carded,” says Bryce Moul­ton, clin­i­cal re­search di­rec­tor for pre­ci­sion ge­nomics at In­ter­moun­tain Health­care. “We have a large elec­tronic health

record, and we have ac­cess to clin­i­cal data as well, along with th­ese sam­ples.” The tis­sue stor­age and anal­y­sis for PRE­CISE will be con­ducted at In­ter­moun­tain’s Trans­la­tional Science Cen­ter in St. Ge­orge, Utah, which lever­ages the power of next-gen­er­a­tion se­quenc­ing and state-of-the-art ge­nomics and is ca­pa­ble of se­quenc­ing thou­sands of genomes an­nu­ally. Re­cruit­ment, en­roll­ment and sam­ple col­lec­tion for the study will take place across the health sys­tem’s hos­pi­tals and clin­ics. In­ter­moun­tain also re­cently an­nounced it is build­ing a new global DNA data­base based on elec­tronic health his­to­ries from peo­ple around the world, which the re­search com­mu­nity will use to de­ter­mine who might be at risk for de­vel­op­ing ge­netic dis­eases.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.